Application of proprotein convertase subtilisin/kexin type 9 inhibitor, evolocumab, in patients with severe hypertriglyceridemia
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Wolters Kluwer
2022-03-01
|
| Serie: | Chinese Medical Journal |
| Länkar: | http://journals.lww.com/10.1097/CM9.0000000000001896 |